NYSE: CIBBancolombia Sa Stock
$40.03+0.50 (+1.26%)
Updated Apr 21, 2025
CIB Price
$40.03
Fair Value Price
N/A
Market Cap
$9.63B
52 Week Low
$30.25
52 Week High
$44.93
P/E
6.38x
P/B
0.93x
P/S
1.5x
PEG
5.84x
Dividend Yield
13.88%
Revenue
$5.34B
Earnings
$1.42B
Gross Margin
100%
Operating Margin
38.68%
Profit Margin
28%
Debt to Equity
7.52
Operating Cash Flow
$99M
Beta
0.74
Next Earnings
May 7, 2025
Ex-Dividend
Apr 28, 2025
Next Dividend
May 9, 2025
CIB Overview
Bancolombia S.A. is a full-service bank operating nine segments: Banking Colombia, Banking El Salvador, Leasing, Trust, Investment, Brokerage, Off Shore, Pension and Insurance, and All Other segments. Formerly known as Banco de Colombia, Bancolombia was founded in 1875 and is headquartered in Medellín, Colombia.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CIB's potential to beat the market
- CIB doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Bank
Industry Rating
F
CIB
RankedUnranked of 296
RankedUnranked of 296
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $12.60 | B | |
| $14.23 | B | |
| $30.90 | B |
Be the first to know about important CIB news, forecast changes, insider trades & much more!
CIB News
Overview
Due Diligence Score
–
Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CIB scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CIB ($40.03) is trading above its intrinsic value of $36.45, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CIB is good value based on its earnings relative to its share price (6.38x), compared to the US market average (27.14x)
P/E vs Market Valuation
CIB is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CIB due diligence checks available for Premium users.
Valuation
CIB price to earnings (PE)
For valuing profitable companies with steady earnings
Company
6.38x
Industry
13.07x
Market
27.14x
CIB is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CIB is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
CIB price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.93x
Industry
1.07x
CIB is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CIB price to earnings growth (PEG)
For valuing profitable companies with growth potential
CIB is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
CIB's financial health
Profit margin
Revenue
$5.1B
Net Income
$1.4B
Profit Margin
28%
CIB's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$84.1B
Liabilities
$74.1B
Debt to equity
7.52
CIB's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CIB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$98.5M
Investing
-$126.4M
Financing
$124.4M
CIB vs Bank Stocks
Bancolombia Sa Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.